Day TA, Penn-Nicholson A, Luabeya AKK, et al. Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial. Lancet Respir Med 2021; 9: 373–86—For this Article, the spelling of Friedrich Thienemann's name was incorrect in the list of TBVPX-203 study team members. This correction has been made to the online version as of June 29, 2021

Article InfoPublication HistoryIdentification

DOI: https://doi.org/10.1016/S2213-2600(21)00281-2

Copyright

© 2021 Elsevier Ltd. All rights reserved.

ScienceDirectAccess this article on ScienceDirect Linked Articles